CRISPR Therapeutics AGCRSPNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank27
Studio
Year-over-Year Change

Year-over-year book value per share growth

Percentile
P27
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 yr
Consecutive declineDecelerating
PeriodValue
2025-6.69%
2024-3.63%
2023-1.48%
2022-23.64%
202125.20%
202046.11%
2019111.20%
201874.04%
2017-75.26%
20162010.96%